BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 27022229)

  • 1. Glucose metabolic phenotype of pancreatic cancer.
    Chan AK; Bruce JI; Siriwardena AK
    World J Gastroenterol; 2016 Mar; 22(12):3471-85. PubMed ID: 27022229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PKM2 Promotes Cell Survival and Invasion Under Metabolic Stress by Enhancing Warburg Effect in Pancreatic Ductal Adenocarcinoma.
    Li C; Zhao Z; Zhou Z; Liu R
    Dig Dis Sci; 2016 Mar; 61(3):767-73. PubMed ID: 26500118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential.
    Knudsen ES; Balaji U; Freinkman E; McCue P; Witkiewicz AK
    Oncotarget; 2016 Nov; 7(48):78396-78411. PubMed ID: 27623078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonase 2 Facilitates Pancreatic Cancer Growth and Metastasis by Stimulating GLUT1-Mediated Glucose Transport.
    Nagarajan A; Dogra SK; Sun L; Gandotra N; Ho T; Cai G; Cline G; Kumar P; Cowles RA; Wajapeyee N
    Mol Cell; 2017 Aug; 67(4):685-701.e6. PubMed ID: 28803777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.
    Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D
    Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyruvate kinase type M2 contributes to the development of pancreatic ductal adenocarcinoma by regulating the production of metabolites and reactive oxygen species.
    Yokoyama M; Tanuma N; Shibuya R; Shiroki T; Abue M; Yamamoto K; Miura K; Yamaguchi K; Sato I; Tamai K; Satoh K
    Int J Oncol; 2018 Mar; 52(3):881-891. PubMed ID: 29393401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness.
    Rademaker G; Hennequière V; Brohée L; Nokin MJ; Lovinfosse P; Durieux F; Gofflot S; Bellier J; Costanza B; Herfs M; Peiffer R; Bettendorff L; Deroanne C; Thiry M; Delvenne P; Hustinx R; Bellahcène A; Castronovo V; Peulen O
    Oncogene; 2018 Aug; 37(32):4398-4412. PubMed ID: 29720728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen.
    Cappello P; Tomaino B; Chiarle R; Ceruti P; Novarino A; Castagnoli C; Migliorini P; Perconti G; Giallongo A; Milella M; Monsurrò V; Barbi S; Scarpa A; Nisticò P; Giovarelli M; Novelli F
    Int J Cancer; 2009 Aug; 125(3):639-48. PubMed ID: 19425054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolyl 4-hydroxylase P4HA1 Mediates the Interplay Between Glucose Metabolism and Stemness in Pancreatic Cancer Cells.
    Cao X; Cao Y; Zhao H; Wang P; Zhu Z
    Curr Stem Cell Res Ther; 2023; 18(5):712-719. PubMed ID: 36043766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GOT1-mediated anaplerotic glutamine metabolism regulates chronic acidosis stress in pancreatic cancer cells.
    Abrego J; Gunda V; Vernucci E; Shukla SK; King RJ; Dasgupta A; Goode G; Murthy D; Yu F; Singh PK
    Cancer Lett; 2017 Aug; 400():37-46. PubMed ID: 28455244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of miR-21 and miR-211 on MMP9 regulation in pancreatic ductal adenocarcinoma: cooperation in invasiveness behaviors?
    Funel N
    Epigenomics; 2015; 7(3):333-5. PubMed ID: 26077422
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic and Functional Significance of MAP4K5 in Pancreatic Cancer.
    Wang OH; Azizian N; Guo M; Capello M; Deng D; Zang F; Fry J; Katz MH; Fleming JB; Lee JE; Wolff RA; Hanash S; Wang H; Maitra A
    PLoS One; 2016; 11(3):e0152300. PubMed ID: 27023625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Topoisomerase 2-Alpha Confers a Poor Prognosis in Pancreatic Adenocarcinoma Identified by Co-Expression Analysis.
    Zhou Z; Liu S; Zhang M; Zhou R; Liu J; Chang Y; Zhao Q
    Dig Dis Sci; 2017 Oct; 62(10):2790-2800. PubMed ID: 28815403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant expression of a disintegrin and metalloproteinase 17/tumor necrosis factor-alpha converting enzyme increases the malignant potential in human pancreatic ductal adenocarcinoma.
    Ringel J; Jesnowski R; Moniaux N; Lüttges J; Ringel J; Choudhury A; Batra SK; Klöppel G; Löhr M
    Cancer Res; 2006 Sep; 66(18):9045-53. PubMed ID: 16982746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal adhesion kinase-promoted tumor glucose metabolism is associated with a shift of mitochondrial respiration to glycolysis.
    Zhang J; Gao Q; Zhou Y; Dier U; Hempel N; Hochwald SN
    Oncogene; 2016 Apr; 35(15):1926-42. PubMed ID: 26119934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxiredoxin 1 promotes pancreatic cancer cell invasion by modulating p38 MAPK activity.
    Taniuchi K; Furihata M; Hanazaki K; Iwasaki S; Tanaka K; Shimizu T; Saito M; Saibara T
    Pancreas; 2015 Mar; 44(2):331-40. PubMed ID: 25426613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased COMT expression in pancreatic cancer and correlation with clinicopathologic parameters.
    Wu W; Zhang J; Zhou L; You L; Zhao Y; Li J
    Sci China Life Sci; 2012 Sep; 55(9):747-52. PubMed ID: 23015122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
    Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C
    Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of β-galactoside α2,6-sialyltransferase 1 in a fructoseresponsive manner promotes pancreatic cancer metastasis.
    Hsieh CC; Shyr YM; Liao WY; Chen TH; Wang SE; Lu PC; Lin PY; Chen YB; Mao WY; Han HY; Hsiao M; Yang WB; Li WS; Sher YP; Shen CN
    Oncotarget; 2017 Jan; 8(5):7691-7709. PubMed ID: 28032597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inducible nitric oxide synthase enhances disease aggressiveness in pancreatic cancer.
    Wang J; He P; Gaida M; Yang S; Schetter AJ; Gaedcke J; Ghadimi BM; Ried T; Yfantis H; Lee D; Weiss JM; Stauffer J; Hanna N; Alexander HR; Hussain SP
    Oncotarget; 2016 Aug; 7(33):52993-53004. PubMed ID: 27367029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.